Placulumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Placulumab
Monoclonal antibody
Type ?
Source Human
Target TNF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
Formula C3404H5262N902O1036S22
Molar mass 78.7 kg/mol

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]

This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association.